Tag Archives: The Lancet
The toxic affair between Covaxin and The Lancet
That Covaxin has been leading a ceaselessly beleaguered life is no mystery – but The Lancet journal may not know that it has been pressed into the questionable service of saving the vaccine’s reputation on at least three occasions. In … Continue reading
Posted in Analysis, Science
Tagged Bharat Biotech, clinical trials, Covaxin, JAMA, New England Journal of Medicine, retraction index, scientific publishing, The Lancet
Comments Off on The toxic affair between Covaxin and The Lancet
On The Lancet editorial
On May 8, The Lancet published an editorial criticising the Narendra Modi government’s response to India’s second COVID-19 outbreak, which has been redefining the meaning of ‘snafu’. All hell broke loose. Of course, hell has been breaking loose for quite … Continue reading
Posted in Scicomm
Tagged COVID-19 epidemic, COVID-19 in India, COVID-19 pandemic, Dr Harsh Vardhan, favipiravir, hydroxychloroquine, Pankaj Chaturvedi, second wave, The Lancet, whataboutery
Comments Off on On The Lancet editorial
A non-self-correcting science
While I’m all for a bit of triumphalism when some component of conventional publication vis-à-vis scientific research – like pre-publication anonymous peer review – fails, and fails publicly, I spotted an article in The Conversation earlier today that I thought … Continue reading
Posted in Science
Tagged COVID-19, hydroxychloroquine, New England Journal of Medicine, peer review, science publishing, scientific publishing, The Conversation, The Lancet
Comments Off on A non-self-correcting science
The costs of correction
I was slightly disappointed to read a report in the New York Times this morning. Entitled ‘Two Huge COVID-19 Studies Are Retracted After Scientists Sound Alarms’, it discussed the implications of two large studies of COVID-19 recently being retracted by … Continue reading
Posted in Science
Tagged COVID-19, Elisabeth Bik, hydroxychloroquine, New England Journal of Medicine, New York Times, peer review, preprint papers, preprints, scientific literature, scientific publishing, The Lancet
Comments Off on The costs of correction
A caveat for peer-review
Now that more researchers are finding more holes in the study in The Lancet, which claimed hydroxychloroquine – far from being a saviour of people with COVID-19 – actually harms them, I wonder where the people are who’ve been hollering … Continue reading
Posted in Science
Tagged Andrew Gelman, chloroquine, COVID-19, hydroxychloroquine, macrolide, open review, peer review, preprint server, The Lancet
Comments Off on A caveat for peer-review
Poor journalism is making it harder for preprints
There have been quite a few statements by various scientists on Twitter who, in pointing to some preprint paper’s untenable claims, point to the manuscript’s identity as a preprint paper as well. This is not fair, as I’ve argued many times before. … Continue reading
Posted in Op-eds, Science
Tagged Ars Technica, COVID-19, journalism, misinformation, peer review, preprint papers, preprint repositories, preprints, press release, science journalism, scientific literature, scientific publishing, The Lancet
Comments Off on Poor journalism is making it harder for preprints
Distracting from the peer-review problem
From an article entitled ‘The risks of swiftly spreading coronavirus research‘ published by Reuters: A Reuters analysis found that at least 153 studies – including epidemiological papers, genetic analyses and clinical reports – examining every aspect of the disease, now called … Continue reading
Posted in Science, Uncategorized
Tagged bioRxiv, cherry-picking, COVID-19, Elisabeth Bik, peer review, preprint papers, preprints, Reuters, Smut Clyde, The Lancet
Comments Off on Distracting from the peer-review problem
Caste, healthcare and statistics
In late November 2014, the esteemed British medical journal The Lancet published an editorial calling for the end of casteism in India to mitigate the deteriorating health of the millions of rural poor, if nothing else. The central argument was that caste was hampering … Continue reading
Posted in Uncategorized
Tagged Amartya Sen, Arundhati Roy, casteism, economic status, healthcare, Jean Dreze, The Lancet
Comments Off on Caste, healthcare and statistics
Three overlooked reasons why India’s healthcare indicators remain abysmal
Scroll.in January 2, 2015 The Bharatiya Janata Party-led Central government announced in July that it would roll out a National Health Assurance Mission, whose aim would be to provide some free medical services to reduce “out of pocket spending on … Continue reading
Posted in Uncategorized
Tagged casteism, health inspectors, import duty, medical tourism, National Health Assurance Mission, Planning Commission, poverty line, Ranbaxy Labs, The Lancet, untouchability, Wockhardt
Comments Off on Three overlooked reasons why India’s healthcare indicators remain abysmal